Literature DB >> 19729471

Plasma uric acid and hypertension in a Chinese community: prospective study and metaanalysis.

Weili Zhang1, Kai Sun, Ying Yang, Hongye Zhang, Frank B Hu, Rutai Hui.   

Abstract

BACKGROUND: Hyperuricemia has been positively associated with hypertension, but whether this association is independent of adiposity and other cardiovascular risk factors remains a matter of debate.
METHODS: We conducted a community-based prospective cohort study comprising 7220 participants (mean age 37 years; 73.8% men) in the Qingdao Port Health and Nutrition Examination Survey in China, who were free from hypertension at study entry in 1999-2000. During 4-year follow-up, 1370 men (19.0%) and 208 women (11.0%) had developed hypertension.
RESULTS: After adjustment for age, body mass index, and other covariates, the relative risks (RRs) of developing hypertension comparing the highest and lowest uric acid quartiles were 1.55 (95% CI 1.10-2.19; P for trend <0.001) for men and 1.91 (1.12-3.25; P for trend <0.001) for women. After additional adjustment for abdominal obesity, the RRs comparing the participants in the highest and lowest quartiles of uric acid were 1.39 (1.16-1.68; P for trend 0.003) for men and 1.85 (1.06-3.24; P for trend 0.006) for women. In joint analysis, compared with those in the lowest uric acid quartile and without abdominal obesity, participants who were in the highest quartile and also had abdominal obesity had a 3.0- and 3.4-fold greater risk of incident hypertension (1.56-3.97 for men and 2.10-3.81 for women, respectively).
CONCLUSIONS: These data suggest a positive association between plasma uric acid and incidence of hypertension during short-term follow-up in a Chinese population. The association between hyperuricemia and hypertension was partly mediated by abdominal obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729471     DOI: 10.1373/clinchem.2009.124891

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  35 in total

1.  Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update.

Authors:  Claudio Borghi; Justyna Domienik-Karłowicz; Andrzej Tykarski; Krystyna Widecka; Krzysztof J Filipiak; Miłosz J Jaguszewski; Krzysztof Narkiewicz; Giuseppe Mancia
Journal:  Cardiol J       Date:  2021-01-13       Impact factor: 2.737

Review 2.  Uric acid and hypertension: cause or effect?

Authors:  Marilda Mazzali; Mehmet Kanbay; Mark S Segal; Mohamed Shafiu; Diana Jalal; Daniel I Feig; Richard J Johnson
Journal:  Curr Rheumatol Rep       Date:  2010-04       Impact factor: 4.592

Review 3.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation.

Authors:  Richard J Johnson; George L Bakris; Claudio Borghi; Michel B Chonchol; David Feldman; Miguel A Lanaspa; Tony R Merriman; Orson W Moe; David B Mount; Laura Gabriella Sanchez Lozada; Eli Stahl; Daniel E Weiner; Glenn M Chertow
Journal:  Am J Kidney Dis       Date:  2018-02-27       Impact factor: 8.860

Review 4.  Improving cardiovascular and renal outcomes in gout: what should we target?

Authors:  Pascal Richette; Fernando Perez-Ruiz; Michael Doherty; Tim L Jansen; George Nuki; Eliseo Pascual; Leonardo Punzi; Alexander K So; Thomas Bardin
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

5.  Hyperuricemia: a reality in the Indian obese.

Authors:  Carlyne Remedios; Miloni Shah; Aparna Govil Bhasker; Muffazal Lakdawala
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

Review 6.  Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Authors:  Peter C Grayson; Seo Young Kim; Michael LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

7.  Reconstruction and analysis of correlation networks based on GC-MS metabolomics data for young hypertensive men.

Authors:  Le Wang; Entai Hou; Lijun Wang; Yanjun Wang; Lingjian Yang; Xiaohui Zheng; Guangqi Xie; Qiong Sun; Mingyu Liang; Zhongmin Tian
Journal:  Anal Chim Acta       Date:  2014-11-11       Impact factor: 6.558

8.  Serum uric acid is an independent predictor for developing prehypertension: a population-based prospective cohort study.

Authors:  L Liu; Y Gu; C Li; Q Zhang; G Meng; H Wu; H Du; H Shi; Y Xia; X Guo; X Liu; X Bao; Q Su; L Fang; F Yu; H Yang; B Yu; S Sun; X Wang; M Zhou; Q Jia; Q Guo; K Song; G Huang; G Wang; K Niu
Journal:  J Hum Hypertens       Date:  2016-07-28       Impact factor: 3.012

Review 9.  Comorbidities in patients with crystal diseases and hyperuricemia.

Authors:  Sebastian E Sattui; Jasvinder A Singh; Angelo L Gaffo
Journal:  Rheum Dis Clin North Am       Date:  2014-02-19       Impact factor: 2.670

10.  The association between serum uric acid and renal damage in a community-based population: the Takahata study.

Authors:  Kazuko Suzuki; Tsuneo Konta; Kosuke Kudo; Hiroko Sato; Ami Ikeda; Kazunobu Ichikawa; Yoshiyuki Ueno; Takeo Kato; Takamasa Kayama; Isao Kubota
Journal:  Clin Exp Nephrol       Date:  2012-11-27       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.